HOXB13 and prostate cancer: These studies establish critical mechanisms for future utilization of MEIS proteins and predictive biomarkers of indolent prostate cancer and will enable mechanistic studies to define the roles of HOXB13 mutants and oncogenic HOXB13 cofactors in prostate cancer progression.